Cite

    Yan, J. et al. (n.d.). Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo. Drug delivery. pp. 1757-1762. [Online].